Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP686399.RAzU0KvO5WlVNINxCwaGXDTUhbF_c-80wlpkJWIGbldzk130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP686399.RAzU0KvO5WlVNINxCwaGXDTUhbF_c-80wlpkJWIGbldzk130_assertion type Assertion NP686399.RAzU0KvO5WlVNINxCwaGXDTUhbF_c-80wlpkJWIGbldzk130_head.
- NP686399.RAzU0KvO5WlVNINxCwaGXDTUhbF_c-80wlpkJWIGbldzk130_assertion wasGeneratedBy ECO_0000203 NP686399.RAzU0KvO5WlVNINxCwaGXDTUhbF_c-80wlpkJWIGbldzk130_provenance.
- NP686399.RAzU0KvO5WlVNINxCwaGXDTUhbF_c-80wlpkJWIGbldzk130_assertion wasDerivedFrom befree-20140225 NP686399.RAzU0KvO5WlVNINxCwaGXDTUhbF_c-80wlpkJWIGbldzk130_provenance.
- NP686399.RAzU0KvO5WlVNINxCwaGXDTUhbF_c-80wlpkJWIGbldzk130_assertion SIO_000772 20430009 NP686399.RAzU0KvO5WlVNINxCwaGXDTUhbF_c-80wlpkJWIGbldzk130_provenance.
- NP686399.RAzU0KvO5WlVNINxCwaGXDTUhbF_c-80wlpkJWIGbldzk130_assertion evidence source_evidence_literature NP686399.RAzU0KvO5WlVNINxCwaGXDTUhbF_c-80wlpkJWIGbldzk130_provenance.
- NP686399.RAzU0KvO5WlVNINxCwaGXDTUhbF_c-80wlpkJWIGbldzk130_assertion description "[In this study, the suppressive effect of PPAR ligands on HBV replication was examined in vitro using a PPARalpha ligand, bezafibrate, and a PPARgamma ligand, rosiglitazone.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP686399.RAzU0KvO5WlVNINxCwaGXDTUhbF_c-80wlpkJWIGbldzk130_provenance.